SCHEMBL6204299

SCHEMBL6204299

CCOCC([O])Cc1c(Cl)cccc1Cl

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.44
POLB P06746 2/20 0.44
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
KMT2A Q03164 1/20 0.36
AKR1B1 P15121 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
HTT P42858 2/20 0.34
ALDH1A1 P00352 4/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
TAAR1 Q96RJ0 1/20 0.33
TDP1 Q9NUW8 2/20 0.33
ALOX15 P16050 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6202381 0.81 SLC6A2 (0.41) CYP1A2CYP3A4CYP2C9CYP2C19KMT2A
SCHEMBL6204860 0.73 TSHR (0.47) POLBCYP1A2ALDH1A1TAAR1
SCHEMBL17055847 0.71 KDM4E (0.53) KDM4EPOLBKMT2AAKR1B1SMN1; SMN2
SCHEMBL6204365 0.71 AKR1B1 (0.39) KDM4EPOLBKMT2AAKR1B1SMN1; SMN2
Ether SCHEMBL27465042 0.69 KDM4E (0.47) KDM4EPOLBCYP1A2CYP3A4CYP2C9
SCHEMBL6201896 0.68 IDO1 (0.38) KDM4EPOLBCYP3A4KMT2AALDH1A1
SCHEMBL9780828 0.68 KMT2A (0.49) KDM4EPOLBCYP1A2CYP3A4CYP2C9
SCHEMBL9780837 0.68 KMT2A (0.49) KDM4EPOLBCYP1A2CYP3A4CYP2C9
SCHEMBL18537078 0.67 TAAR1 (0.41) POLBCYP1A2CYP3A4NPSR1AKR1B1
SCHEMBL4486331 0.67 ALDH1A1 (0.32) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 EP disclosed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 WO disclosed